75,000 people sign up for app-based trials; Clot removal for stroke reduces hospital stay;

@FierceMedDev: Docs dole out recs for reducing fetal ultrasound procedures in the U.S. Story | Follow @FierceMedDev

@EmilyWFierce:#FDA launches probe into safety of common MRI contrast agent. Article | Follow @EmilyWFierce

The Associated Press takes a look at how the smartphone is being incorporated into medical research. It notes that more than 75,000 people have enrolled for clinical trials involving Apple ($AAPL) apps. Story

Glasgow University has been awarded £3.4 million from the Medical Research Council to create a molecular pathology laboratory. Story

Molecular Dx player AutoGenomics has withdrawn a proposed IPO for the third time. More

A U.K. study found that the use of mechanical thrombectomy to treat stoke reduced the average patient's hospital stay to 14 days from 90 days with more than 90% of these patients discharged to go home, rather than go to a nursing home. More

Biotech News

@FierceBiotech: Cutting-edge research centers back Deerfield's $550M biotech venture fund. Story | Follow @FierceBiotech

@JohnCFierce: This just in, $SFY has decided to outsource all pipeline work and restrict R&D effort to writing checks. $REGN $ALNY | Follow @JohnCFierce

@DamianFierce: Marc Beer resignation PR includes a line about continuing "the company's commitment to high integrity and ethics." | Follow @DamianFierce

Progenics' orphan cancer drug picks up the FDA's 'breakthrough' tag. Article

Cutting-edge research centers back Deerfield's $550M biotech venture fund. More

Esperion looks to disrupt the PCSK9 race with new cardio data. News

Pharma News

@FiercePharma: $BMY CEO talks up immuno-oncology space, coming hep C competition in Japan. Article | Follow @FiercePharma

@EricPFierce: ICYMI: Lupin lands its first US manufacturing site with $880M deal for GAVIS, 6-year-old NJ firm. More | Follow @EricPFierce

@CarlyHFierce: About that brand/generics hybrid thing? Make that brands only, Allergan says with Teva deal. News | Follow @CarlyHFierce

Pfizer lifts guidance as Prevnar, Ibrance trigger Q2 beats. More

Hikma shells out $2.65B for Boehringer's U.S. generics business. Story

Drug Delivery News

IPOs: EyeGate tries again following deal with Valeant, Parkinson's specialist to debut soon. More

Alnylam launches trial of one of its RNAi candidates. Article

Pill holds a ring-shaped device that could deliver drugs to the stomach long-term. Story

ASU team offers precise DNA origami technique with novel shapes and delivery potential. More

Ra Pharma gets $58.5M to challenge a rare disease's intravenous incumbent. Article

Pharma Manufacturing News

Avista Pharma snaps up NC manufacturing facility from rival Scynexis. Report

Teva expands recall of cancer drug Adrucil. Story

Androxy returns to market after 9-month lapse. News

EU ban on more than 700 drugs set for Aug. 21. Item

Hospira recall of ketorolac now close to 40 million vials. Article

Pharma Asia News

Fallout from India's GVK means $1B lost in drug exports by March 2016. News

Trans-Pacific Partnership impasse on data exclusivity for biologics softens. Story

Roche COO O'Day highlights emerging markets trends on Q2 call. More

Eli Lilly execs on Q2 call discuss Japan opportunities, China slowdown. Article

EU-wide ban starts Aug. 21 on 700-plus drugs tested by India's GVK Bio Sciences. Report